Neurobehavioral Disorders Negative Allosteric Modulator Gets Fast Track Status for Social Anxiety Disorder Publish Date December 8, 2021 The Company will evaluate BNC210 in patients with SAD in the phase 2 PREVAIL trial.
Neurobehavioral Disorders Prescription Digital Therapeutic for Anxiety, Depression Treatment Launched Publish Date July 29, 2021 Ensemble is an AI-powered digital mental health coach app designed to address the symptoms of MDD or GAD.